{
  "report_rows": [
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1,105M vs. cons $1,092.7M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS Diluted Operating (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.340 vs. cons $0.339",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA Margin (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~23.1% vs. cons 23.40%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Organic Growth (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide '7%-8%' vs. cons 7.19%",
      "confidence": "HIGH"
    },
    {
      "kpi": "Incremental Margin Target (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide '25%-30% near-term' reaffirmed vs. cons ~23.5% implied",
      "confidence": "HIGH"
    },
    {
      "kpi": "Insurance/Claims Tone (H2 2026)",
      "prediction": "UNCHANGED",
      "answer": "cautious - improving lead indicators but no specific moderation commitment",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH then partial fade - revenue beat drives modest upward revision, margin miss pulls FY EPS estimates slightly lower",
  "day5_confidence": "MEDIUM"
}